300238 冠昊生物
按盤價 
13.510 -0.500 (-3.569%)
13.510 -0.500 (-3.569%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.218 | 6.165 | -48.504 | 9.733 | 6.464 |
| 總資產報酬率 ROA (%) | 3.951 | 4.597 | -34.802 | 6.598 | 4.080 |
| 投入資產回報率 ROIC (%) | 4.336 | 5.169 | -39.419 | 7.594 | 4.738 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.637 | 79.126 | 76.246 | 75.114 | 72.528 |
| 營業利潤率 (%) | 11.324 | 8.409 | -77.406 | 16.679 | 10.290 |
| 息稅前利潤/營業總收入 (%) | 11.499 | 9.263 | -76.086 | 18.174 | 12.508 |
| 淨利潤/營業總收入 (%) | 7.428 | 5.214 | -86.841 | 10.376 | 9.465 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 90.041 | 136.150 | -5.834 | 81.748 | 87.941 |
| 價值變動淨收益/利潤總額(%) | 2.571 | -11.344 | 3.760 | -5.710 | -7.000 |
| 營業外收支淨額/利潤總額(%) | -0.521 | -5.919 | 0.185 | 0.608 | -0.196 | 償債能力分析 |
| 流動比率 (X) | 1.665 | 1.547 | 1.582 | 1.660 | 1.447 |
| 速動比率 (X) | 1.207 | 1.133 | 1.255 | 1.124 | 1.028 |
| 資產負債率 (%) | 35.498 | 32.764 | 35.706 | 31.907 | 0.368 |
| 帶息債務/全部投入資本 (%) | 15.167 | 7.296 | 10.371 | 9.534 | 18.988 |
| 股東權益/帶息債務 (%) | 528.479 | 1,184.959 | 783.020 | 852.859 | 393.881 |
| 股東權益/負債合計 (%) | 210.768 | 234.149 | 202.793 | 223.610 | 174.677 |
| 利息保障倍數 (X) | 49.398 | 6.999 | -51.983 | 13.049 | 5.589 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 60.600 | 59.284 | 85.248 | 82.110 | 102.811 |
| 存貨周轉天數 (天) | 333.711 | 284.357 | 406.164 | 395.607 | 339.183 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 15/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
